Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014518 · ClinicalTrials.gov registry record
Biomarkers as Predictors of Suicidal Risk in Adolescents
A clinical trial of Suicide and Suicidal Ideation, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT03014518: Completed study of Suicide and Suicidal Ideation, sponsored by The Cleveland Clinic.
NCT03014518 is a study of Suicide and Suicidal Ideation that has completed, run by The Cleveland Clinic. The registered enrollment target is 80 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03014518, a study of Suicide and Suicidal Ideation, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Suicide is one of the most devastating events in society at all levels. The primary goal of this study is to predict suicide in adolescents at risk. We will utilize blood biomarker measurement and clinical risk factor scales to develop a tool to identify adolescents at risk for suicide earlier, which will allow clinicians to prescribe timely treatment and prevent suicide.
Primary Outcome
Comparison of the levels of peripheral inflammatory markers (S100B, IL-6, IL-1β, TNF-α, kynurenic acid, quinolinic acid, and picolinic acid) between participants with and without suicide attempt
Conditions Studied
Interventions
- OTHER Clinical assessments and blood samples; follow-up for 12 mos
- OTHER Clinical assessments and blood samples; no 12mo follow-up
Study Locations (1)
Ohio
- The Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-12 |
| Est. Completion | 2021-06-28 |
What the finished NCT03014518 record still lists
NCT03014518 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Clinical assessments and blood samples; follow-up for 12 mos is the first listed.
NCT03014518 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03014518 about?
NCT03014518 is a clinical study titled "Biomarkers as Predictors of Suicidal Risk in Adolescents". Suicide is one of the most devastating events in society at all levels. The primary goal of this study is to predict suicide in adolescents at risk. We will utilize blood biomarker measurement and clinical risk factor scales to develop a tool to identify adolescents at risk for suicide earlier, whic...
What is the current status of trial NCT03014518?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-12. Estimated completion is 2021-06-28.
What conditions does trial NCT03014518 study?
This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide, Attempted, Suicidal Intention.
What interventions are being tested in trial NCT03014518?
The interventions under investigation include: Clinical assessments and blood samples; follow-up for 12 mos (OTHER), Clinical assessments and blood samples; no 12mo follow-up (OTHER).
Who is sponsoring clinical trial NCT03014518?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03014518 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03014518's enrollment target sits among peer trials
80 54th of 92 higher than 37 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia